West LA Times

GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager, TriKE® platform, today announced that management will present in-person at H.C. Wainwright’s 24th Annual Global Investment Conference taking place September 12-14, 2022 at the Lotte New York Palace. Company management will also be participating in 1x1 meetings during the event.

H.C. Wainwright 24th Annual Global Investment Conference – September 12-14, 2022
Title:	GT Biopharma (GTBP) Company Presentation
Date:	Tuesday, September 13, 2022
Time:	10:30 – 11:00 am EDT
Location:	Kennedy II, 4th Floor, Lotte New York Palace
Webcast Link:	Register here
*a replay of the presentation will be available for 90 days

If you are interested in arranging a 1x1 meeting request with management, please contact your bank conference representative. To access the archived recording for replay, please see the Presentations section of GT Biopharma’s corporate website.

Original source can be found here.